Lululemon's 20% drop does not make it a buy, because its brand is losing ground in its biggest markets and guidance collapsed. Q2 EPS beat on margins, but constant-currency comps fell 10%, with the first declines on record in China and Rest of World, after brand damage from the proxy fight, a Texas PFAS probe and a yoga event backlash. Management cut fiscal 2026 EPS to $9.48-9.73 on sales down 5-7%, and guided Q3 EPS to $0.93-0.98, about 60% below the Street's $2.37. x.comÂ